Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer

Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer

US Patent 8492413 · Granted Jul 23, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selenophenochromene hydroxamic acids, preparation and use as angiogenesis inhibi2024
Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of 2019
Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment 2018
Thieno [2,3-b] pyridines as multidrug resistance modulators2018
N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and ph2016
N-Carbamoylmethy1-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and ph2015
4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of c2015
Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid2012
Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitor2011
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modula2011
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors2011
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modula2011